跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Moxgen-457 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Moxgen-457
Approved
STANDARD
Moxgen-457
Giyaan Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0c04e9d4bdcfe379
Company
Giyaan Pharma Private Limited
Type
Standard
Approval Details
Approval Id
0c04e9d4bdcfe379
Drug Approval Philippines Name
Moxgen-457
Product Name
Moxgen-457
Registration Number
DRP-5966-11
Brand Name
Moxgen-457
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Suspension
Dosage Strength
457 mg/5 mL
Manufacturer
Giyaan Pharma Private Limited
Importer
Ambica International Trading Corp.
Distributor
Quad-Gen Pharmaceuticals
Issuance Date
25 April 2024
Expiry Date
27 January 2030
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0c04e9d4bdcfe379
Type
Standard
Back to Philippines FDA Approvals